Report Categories
View AllRecent Articles
View All
CIMB Chimera Pr B quarterly earnings data remains undisclosed as internal review processes wrap up
PFD Flaherty and releases latest quarterly earnings no major metric surprises against consensus analyst forecasts
EIKN Eikon Therapeutics CEO outlines strategic pipeline expansion priorities ahead of key clinical trial milestones
What separates ADSTEC ADSE from the pack Technical Weakness 20260508